Molecular biomarkers for aflatoxins and their application to human cancer prevention

John Davis Groopman, Gerald N. Wogan, Bill D. Roebuck, Thomas W Kensler

Research output: Contribution to journalArticle

Abstract

The rapidly expanding understanding of the progressive processes of carcinogenesis provides opportunities for the identification of molecular biological markers reflecting events from exposure through clinical disease. These molecular biological markers can be classified into categories of markers of exposure reflecting the dose of toxic agents, markers of effect indicating a biological response to exposure, and markers of susceptibility providing information about the inherent sensitivity of individuals to the toxic agents. By definition some of these markers are chemical agent specific, such as a carcinogen-DNA or -protein adduct, while others are biological process specific, such as the altered expression of a gene. This article reviews the development and validation of molecular biomarkers of aflatoxins using experimental and human population studies. The development of molecular biomarkers for aflatoxins is based upon the extensive research database available about their metabolism, macromolecular adduct formation, and general mechanisms of action. The long-term goal of the research described in this paper is the application of aflatoxin biomarkers to the development of preventive interventions in human populations at high risk for liver cancer.

Original languageEnglish (US)
JournalCancer Research
Volume54
Issue number7 SUPPL.
StatePublished - Apr 1 1994

Fingerprint

Aflatoxins
Biomarkers
Poisons
Neoplasms
Biological Phenomena
Liver Neoplasms
Research
Carcinogens
Carcinogenesis
Databases
Gene Expression
DNA
Population
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Molecular biomarkers for aflatoxins and their application to human cancer prevention. / Groopman, John Davis; Wogan, Gerald N.; Roebuck, Bill D.; Kensler, Thomas W.

In: Cancer Research, Vol. 54, No. 7 SUPPL., 01.04.1994.

Research output: Contribution to journalArticle

@article{5104acfa308844e4821fc0c13c559446,
title = "Molecular biomarkers for aflatoxins and their application to human cancer prevention",
abstract = "The rapidly expanding understanding of the progressive processes of carcinogenesis provides opportunities for the identification of molecular biological markers reflecting events from exposure through clinical disease. These molecular biological markers can be classified into categories of markers of exposure reflecting the dose of toxic agents, markers of effect indicating a biological response to exposure, and markers of susceptibility providing information about the inherent sensitivity of individuals to the toxic agents. By definition some of these markers are chemical agent specific, such as a carcinogen-DNA or -protein adduct, while others are biological process specific, such as the altered expression of a gene. This article reviews the development and validation of molecular biomarkers of aflatoxins using experimental and human population studies. The development of molecular biomarkers for aflatoxins is based upon the extensive research database available about their metabolism, macromolecular adduct formation, and general mechanisms of action. The long-term goal of the research described in this paper is the application of aflatoxin biomarkers to the development of preventive interventions in human populations at high risk for liver cancer.",
author = "Groopman, {John Davis} and Wogan, {Gerald N.} and Roebuck, {Bill D.} and Kensler, {Thomas W}",
year = "1994",
month = "4",
day = "1",
language = "English (US)",
volume = "54",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7 SUPPL.",

}

TY - JOUR

T1 - Molecular biomarkers for aflatoxins and their application to human cancer prevention

AU - Groopman, John Davis

AU - Wogan, Gerald N.

AU - Roebuck, Bill D.

AU - Kensler, Thomas W

PY - 1994/4/1

Y1 - 1994/4/1

N2 - The rapidly expanding understanding of the progressive processes of carcinogenesis provides opportunities for the identification of molecular biological markers reflecting events from exposure through clinical disease. These molecular biological markers can be classified into categories of markers of exposure reflecting the dose of toxic agents, markers of effect indicating a biological response to exposure, and markers of susceptibility providing information about the inherent sensitivity of individuals to the toxic agents. By definition some of these markers are chemical agent specific, such as a carcinogen-DNA or -protein adduct, while others are biological process specific, such as the altered expression of a gene. This article reviews the development and validation of molecular biomarkers of aflatoxins using experimental and human population studies. The development of molecular biomarkers for aflatoxins is based upon the extensive research database available about their metabolism, macromolecular adduct formation, and general mechanisms of action. The long-term goal of the research described in this paper is the application of aflatoxin biomarkers to the development of preventive interventions in human populations at high risk for liver cancer.

AB - The rapidly expanding understanding of the progressive processes of carcinogenesis provides opportunities for the identification of molecular biological markers reflecting events from exposure through clinical disease. These molecular biological markers can be classified into categories of markers of exposure reflecting the dose of toxic agents, markers of effect indicating a biological response to exposure, and markers of susceptibility providing information about the inherent sensitivity of individuals to the toxic agents. By definition some of these markers are chemical agent specific, such as a carcinogen-DNA or -protein adduct, while others are biological process specific, such as the altered expression of a gene. This article reviews the development and validation of molecular biomarkers of aflatoxins using experimental and human population studies. The development of molecular biomarkers for aflatoxins is based upon the extensive research database available about their metabolism, macromolecular adduct formation, and general mechanisms of action. The long-term goal of the research described in this paper is the application of aflatoxin biomarkers to the development of preventive interventions in human populations at high risk for liver cancer.

UR - http://www.scopus.com/inward/record.url?scp=0028293321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028293321&partnerID=8YFLogxK

M3 - Article

C2 - 8137310

AN - SCOPUS:0028293321

VL - 54

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7 SUPPL.

ER -